MS Views and News Be empowered with MS views and news. To receive The MS BEACON e-Newsletter, CLICK HERE - -

Visit our MS learning channel on YouTube, which provides hundreds of MS educational videos presented by MS Experts from across the USA. Archived here: -- Also please visit our Social media platforms: Facebook, Twitter, and Instagram . Each providing important information for the MS community. Furthermore, scroll down the left side of this blog to learn from the resources and links.

Disclaimer: 'MS Views and News' DOES NOT endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, for your personal knowledge and to keep you informed of current health-related issues. It is not a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.


Tuesday, September 15, 2015

CME - Following the Evidence: A Practical, Case-based Approach to Improving Quality of Life in MS Patients is a CME-certified webcourse

Following the Evidence: A Practical, Case-based Approach to Improving Quality of Life in MS Patients is a CME-certified webcourse that provides neurologists and MS specialists with the latest research and clinical management information on DMD therapies, diagnostic MRI measures, and biomarkers.

View the course online at:

This activity is intended for MS specialists, neurologists, and other health care professionals who manage patients with MS.

There is a general consensus that early diagnosis of multiple sclerosis (MS) and rapid initiation of disease-modifying drug (DMD) therapy are associated with better patient outcomes via delayed progression, better quality of life, and a longer time to onset of disability. However, diagnostic uncertainty, indecision caused by the ongoing emergence of new agents, and patient reluctance to begin treatment all lead to delays in treatment initiation.

The ongoing emergence of new DMDs forces clinicians to face more treatment choices, making the formulation of optimal DMD therapies increasingly complex. In addition, patient concerns with DMD side effects, treatment preferences, drug costs, and other issues negatively impact acceptance of and adherence to DMD treatments. Improved patient engagement and patient-centered care, as well as more comprehensive management of treatment-related side effects and common MS comorbidities, are emerging as other important areas of focus in MS care.

“Following the Evidence: A Practical, Case-based Approach to Improving Quality of Life in MS Patients” uses a case-based approach to explore these issues and discuss the latest advances in MS diagnosis and management, so that neurologists and MS specialists can optimize outcomes for their patients with MS.

Patricia K. Coyle, MD, FAAN, FANA
Professor and Vice Chair (Clinical Affairs)
Department of Neurology
Director, MS Comprehensive Care Center
Stony Brook University Medical Center
Stony Brook, NY

Stephen Krieger, MD
Associate Professor of Neurology
Corinne Goldsmith Dickinson Center for MS
Icahn School of Medicine at Mount Sinai
New York, NY
At the conclusion of this activity, participants should be able to demonstrate the ability to:
  • Describe the mechanisms of action and efficacy and safety profiles of current and emerging DMD therapies in MS
  • Initiate evidence-based, patient-tailored therapies earlier in the course of MS
  • Recognize the barriers to DMD-treatment adherence and formulate patient-engagement strategies and therapies that optimize adherence and effectiveness
  • Improve the recognition and management of common treatment-related side effects and MS comorbidities to improve the care of patients with MS
      Welcome and Introduction
      Advances in Early Diagnosis and DMD Initiation in MS
      Emerging Concepts in MS Management
      Panel Discussion
      Q&A Session, Practice Pearls, and Concluding Remarks
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Potomac Center for Medical Education and Rockpointe. The Potomac Center for Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Potomac Center for Medical Education designates this enduring activity for a maximum of 1.25 AMA PRA Category I Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

For questions regarding CME credit, the post-test, or evaluation, please email
Potomac Center for Medical Education (PCME) adheres to the policies and guidelines, including the Standards for Commercial Support, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous.

All persons in a position to control the content of a continuing medical education program provided by the Potomac Center for Medical Education are required to disclose any relevant financial relationships with any commercial interest to PCME as well as to learners. All conflicts of interest are identified and resolved by PCME in accordance with the Standards for Commercial Support in advance of delivery of the activity to learners.

The content of this activity was vetted by an external medical reviewer to assure objectivity and that the activity is free of commercial bias.
Jointly provided by Potomac Center for Medical Education and Rockpointe

Supported by an educational grant from: Teva Pharmaceuticals and Genentech

The CMSC and NPA do not certify this program for Continuing Education Credit and do not take responsibility for the quality or evidence upon which the content has been based or the faculty chosen.

©2015 Rockpointe


No comments: